A. Pascalis

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

Luca Antiga, Andrea Remuzzi, Paolo Brambilla, 2013, The Lancet.

Cardiovascular Phenotype in Patients with Autosomal Dominant Polycystic Kidney Disease : Current State , Screening and Prevention

A. Pascalis, F. Floccari, A. Bellasi, 2016 .

Vascular and Valvular Calcifications in Chronic Kidney Disease: An Update

C. Ronco, L. Russo, A. Pascalis, 2015, EMJ Nephrology.

Biologics in Wound Management

A. Pascalis, V. Dini, 2020 .

Surrounding skin management in venous leg ulcers: A systematic review.

A. Pascalis, M. Romanelli, T. Oranges, 2020 .

Anemia in Patients with Chronic Kidney Disease: Current Screening and management Approaches

M. Alibrandi, A. Pascalis, F. Floccari, 2016 .

Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data

C. Ronco, M. Fusaro, M. Ravera, 2018, Journal of Nephrology.

Bio-Markers and Cardiorenal Disease: Prognostic and Clinical Relevance

M. Timio, A. Pascalis, A. Granata, 2012 .

Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies.

C. Ronco, A. Pascalis, F. Floccari, 2016, International journal of cardiology.

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

L. Antiga, N. Perico, G. Remuzzi, 2013, The Lancet.

Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes.

A. Pascalis, G. La Manna, S. Stefoni, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.

C. Ronco, M. Galliani, L. Russo, 2017, Thrombosis research.